Riskpilot← Back to searchSign inGet full accessSP Medical AB
ABActiveOrg 5592341928Åsgränd 2 AGeneral medical practice activities · NACE 8621Est. 20190 employees
Revenue 2025
SEK 69K
-40% vs 2024
EBITDA margin
42.5%
+478% vs 2024
Equity ratio
73.2%
Financial strength
Net profit 2025
SEK 24K
+447% vs 2024
| Revenue | SEK 69K | -40% |
| EBITDA | SEK 29K | +478% |
| Net profit | SEK 24K | +447% |
| Total assets | SEK 92K | +41% |
| Equity | SEK 67K | +56% |
| Employees | 0 | — |
Legal name
SP Medical AB
Org number
5592341928
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 december 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva verksamhet inom medicinsk vård, skönhetsvård samt förvalta och inneha värdepapper och därmed förenlig verksamhet.
Address
Åsgränd 2 A
Email
spmedicalab@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 185 | 313 | 371 | 116 | 69 |
| Staff expenses | — | −1 | −0 | −15 | −2 |
| EBITDA | 87 | 193 | 302 | −8 | 29 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 87 | 193 | 302 | −8 | 29 |
| Net financials | — | −0 | 1 | 1 | −1 |
| Profit before tax | 87 | 193 | 303 | −7 | 29 |
| Tax | −16 | −40 | −62 | — | −5 |
| Net profit | 71 | 153 | 241 | −7 | 24 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 164 | 310 | 427 | 65 | 92 |
| Equity | 111 | 203 | 291 | 43 | 67 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 53 | 107 | 136 | 22 | 25 |
| Total debt | 53 | 107 | 136 | 22 | 25 |
EBITDA margin
42.5%
This company
15.8%
Market median
+169% vs market
20212025
Equity ratio
73.2%
This company
38.2%
Market median
+92% vs market
20212025
Return on equity
36.0%
This company
18.4%
Market median
+96% vs market
20212025
Net profit margin
35.1%
This company
8.1%
Market median
+333% vs market
20212025
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20212025
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
BT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
SC Chief Executive Officer | Chief Executive Officer | 2020 |
BT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SP Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Torgny John S P Gullbrand | Deputy Chief Executive Officer | 0 companies |
| Sarah Carolina Gullbrand | Chief Executive Officer | 0 companies |
| Björn Torgny John S P Gullbrand | Deputy Chief Executive Officer | 0 companies |